Our company’s name was inspired by Miach, a mythical Irish healer. Miach Orthopaedics, like this healer, is dedicated to designing technologies intended to facilitate new tissue growth. The company is developing bio-engineered surgical implants for connective tissue repair. Our initial focus is on the Bridge-Enhanced® ACL Repair (BEAR®) technology as a viable alternative to conventional ACL reconstruction for patients who have sustained an anterior cruciate ligament (ACL) injury.
The BEAR technology was pioneered by Martha Murray, M.D., at Boston Children’s Hospital Department of Orthopaedic Surgery before establishing Miach Orthopaedics as a privately held company located in the Boston area.
Martha Shadan has more than three decades of experience in the life science industry as a business leader in a variety of both large and start-up organizations. In 2013, Martha joined Rotation Medical, Inc. as president and chief executive officer, and the company was acquired by Smith & Nephew in December 2017. Prior to joining Rotation Medical, Martha was the president of the Trauma Division at Zimmer where she managed the P&L for the global business. Martha served at Covidien as vice president/general manager of Vascular Therapies and vice president/general manager BioSurgery and Sports Surgery. Other companies that have benefited from Martha's experience and leadership include Bristol Myers Squibb Co. and Merck Millipore.
Martha is the chairwoman of the Board of Directors for a medical device start-up, IlluminOss. She has served on the AdvaMed Board of Directors since 2017, the AdvaMed Accel Board of Directors since 2015 and has been appointed the chairwoman of the Accel Board of Directors. Accel is the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical technology manufacturers. Martha was also a founding member of the Leadership Circle for AdvaMed's Women's Executive Network (WEN).
Martha holds an M.B.A. from Northeastern University, an M.S. in biology from Michigan State University and a B.S. in biology from the University of New Hampshire.
Martha Murray, M.D., is founder and chief medical officer of Miach Orthopaedics. She is also a professor of orthopaedic surgery at Harvard Medical School and a practicing orthopaedic surgeon in the Sports Medicine Division at Boston Children’s Hospital. Dr. Murray has specialized in the care of patients with knee injuries, and she is internationally recognized as an expert in the care of sports injuries of the knee, including ACL, meniscus and osteochondritis dissecans lesions, for the past 15 years.
Dr. Murray pioneered the BEAR implant with initial research funding provided by the NFL Players Association, Boston Children’s Hospital and the National Institutes of Health.
Dr. Murray has over 70 publications in the area of ACL and meniscus surgery. She has won multiple national awards for her work advancing the care of patients with these injuries, including the Kappa Delta and Cabaud Memorial Awards, respectively the highest research awards in orthopedic surgery and sports medicine.
Dr. Murray received her master’s degree in materials science and engineering from Stanford University and her medical degree from the University of Pennsylvania. She completed a residency in orthopedic surgery at Harvard Medical School and fellowships in pediatric orthopedics and sports medicine at Boston Children’s Hospital.
Martha Shadan, President & Chief Executive Officer
Martha Murray, M.D., Founder and Chief Medical Officer
Jim Ness, Chief Financial Officer
Pieter Wolters, Managing Director, DSM Venturing
Joyce Erony, Managing Partner, Amzak Health
Sean Sansiveri, Vice President, National Football League Players Association
Chad Mathis, M.D., Medical Senior Director, Smith & Nephew
Richard Parker, M.D., President, Hillcrest Hospital, Eastern Region Hospitals; Staff Physician, Cleveland Clinic